EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases

Matilda Iemmolo, Giulio Ghersi iD, Giulia Bivona iD

International Journal of Molecular Sciences · 28.04.2023 · 24 (9) · 8026

DOI: 10.3390/ijms24098026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.04.2023. Verfasst von Matilda Iemmolo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128 Palermo, Italy. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Alzheimer Disease. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation plays a fundamental role in the development and progression of neurodegenerative diseases. It could therefore be said that neuroinflammation in neurodegenerative pathologies is not a consequence but a cause of them and could represent a therapeutic target of neuronal degeneration. CX3CL1 and several proteases (ADAMs/MMPs) are strongly involved in the inflammatory pathways of these neurodegenerative pathologies with multiple effects. On the one hand, ADAMs have neuroprotective and anti-apoptotic effects; on the other hand, they target cytokines and chemokines, thus causing inflammatory processes and, consequently, neurodegeneration. CX3CL1 itself is a cytokine substrate for the ADAM, ADAM17, which cleaves and releases it in a soluble isoform (sCX3CL1). CX3CL1, as an adhesion molecule, on the one hand, plays an inhibiting role in the pro-inflammatory response in the central nervous system (CNS) and shows neuroprotective effects by binding its membrane receptor (CX3CR1) present into microglia cells and maintaining them in a quiescent state; on the other hand, the sCX3CL1 isoform seems to promote neurodegeneration. In this review, the dual roles of CX3CL1 and ADAMs/MMPs in different neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (MH), and multiple sclerosis (MS), are investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAlzheimer DiseaseHumansCytokinesNeuroinflammatory DiseasesChemokine CX3CL1Central Nervous SystemMicroglia

Stichwörter der Autor:innen

ADAM’sCX3CL1FraktalineMMP’sneurodegeneration

Substanzen

CytokinesChemokine CX3CL1CX3CL1 protein, human

Autor:innen und Institutionen

  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128 Palermo, Italy.
  • Department of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, 90133 Palermo, Italy.

ORCID-Profile: Giulio Ghersi, Giulia Bivona

Zitieren

APA

Iemmolo, M., Ghersi, G., & Bivona, G. (2023). The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases. International Journal of Molecular Sciences, 24(9), 8026. https://doi.org/10.3390/ijms24098026

Vancouver

Iemmolo M, Ghersi G, Bivona G. The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023;24(9):8026. doi:10.3390/ijms24098026

BibTeX
@article{Iemmolo2023,
  author = {Iemmolo, Matilda and Ghersi, Giulio and Bivona, Giulia},
  title = {The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {8026},
  doi = {10.3390/ijms24098026}
}
Kostenlos starten →